Ovarian cancer stage 1a highly differentiated should be aggressively operated, and whether chemotherapy is needed should be clarified according to pathological evaluation after operation.
Ovarian cancer stage 1a hyperfractionated belongs to the ovarian cancer with relatively low malignancy and very early staging, and can often be cured by aggressive surgical resection.
Postoperative pathologic assessment, whether there is a risk of recurrence, such as vascular infiltration, can consider adjuvant chemotherapy to reduce the probability of recurrence and metastasis.
Since often patients are not symptomatic at this time, diagnosis is difficult in terms of symptoms, and most are detected at screening.
Aggressive clinical intervention in this group of patients can often achieve better treatment results, and the cure rate can be more than 90%, so it is the best time for treatment.